
Edwards Lifesciences Corporation EW
€ 68.31
-4.04%
Geschäftsbericht 2025
hinzugefügt 25.02.2026
Edwards Lifesciences Corporation Kurzfristige Verbindlichkeiten 2011-2026 | EW
Kurzfristige Verbindlichkeiten Jährlich Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.81 B | 1.51 B | 1.2 B | 1.02 B | 1.03 B | 894 M | 902 M | 877 M | 1.4 B | 532 M | 476 M | 434 M | 346 M | 347 M | 335 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.81 B | 335 M | 874 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
Align Technology
ALGN
|
2.04 B | $ 165.05 | -6.92 % | $ 12.4 B | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
219 M | $ 10.98 | -4.69 % | $ 1.65 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
16.5 B | $ 105.06 | 0.47 % | $ 183 B | ||
|
Accuray Incorporated
ARAY
|
193 M | $ 0.39 | 3.73 % | $ 40.1 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 34.24 | -3.13 % | $ 5.1 K | ||
|
Boston Scientific Corporation
BSX
|
5.44 B | $ 69.19 | -1.4 % | $ 102 B | ||
|
ClearPoint Neuro
CLPT
|
10.8 M | $ 9.18 | -2.25 % | $ 260 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
Electromed
ELMD
|
10.5 M | $ 24.63 | 0.74 % | $ 208 M | ||
|
CONMED Corporation
CNMD
|
315 M | $ 35.38 | -3.44 % | $ 1.1 B | ||
|
Establishment Labs Holdings
ESTA
|
82.1 M | $ 55.71 | -7.01 % | $ 1.65 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 18.55 | 0.03 % | $ 122 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Helius Medical Technologies
HSDT
|
1.88 M | $ 1.92 | -4.48 % | $ 1.17 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.32 | -0.64 % | $ 718 M | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Inogen
INGN
|
63.5 M | $ 6.27 | -3.54 % | $ 167 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.59 | -1.5 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
1.9 M | $ 2.24 | -1.32 % | $ 3.5 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 11.25 | -1.4 % | $ 1.52 B | ||
|
Penumbra
PEN
|
183 M | $ 335.11 | -0.39 % | $ 13 B | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 15.72 | -3.85 % | $ 369 M | ||
|
LivaNova PLC
LIVN
|
808 M | $ 61.25 | -3.77 % | $ 3.34 B | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
7.58 M | - | 10.0 % | $ 610 K | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 0.99 | -26.48 % | $ 16 M | ||
|
IRadimed Corporation
IRMD
|
10.2 M | $ 97.44 | -1.32 % | $ 1.24 B | ||
|
Myomo
MYO
|
8.35 M | $ 0.67 | -1.56 % | $ 28 M |